Latest Content

Straight to the source – targeted pain relief

Diamyd Medical, a Swedish biopharmaceutical company, has taken huge steps towards revolutionising the treatment of intractable pain. Through their Nerve Targeting Drug Delivery System (NTDDS) the developers hope to bring new relief to cancer, diabetes and chronic pain sufferers. Dr Nicola Davies reports.

Snapshot: The market for neuropathic pain therapeutics

As conditions such as diabetes become more common, the market for new pain drugs is becoming increasingly competitive. Using detailed GlobalData research this snapshot examines the market forces behind a sector expected to grow by 9.6% from $4.8bn in 2010 to $10bn in 2018.

Preventing the Fallout: Anti-Radiation Drugs

The disaster at the Fukushima nuclear plant in Japan has triggered demand for a powerful anti-radiation drug. Elisabeth Fischer finds out what options are currently out there and asks just how prepared are countries in the face of a nuclear fallout?

Related Treatments


Go Top